Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports the development of potent enzyme inhibitors due to the presence of the trifluoromethyl group and the strained azetidine ring. Commonly employed in medicinal chemistry for constructing conformationally constrained analogs, enhancing metabolic stability and binding affinity in drug candidates. Also utilized in the preparation of CF3-substituted heterocycles for PET tracer development and agrochemical research.